These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3549022)

  • 21. Artificial oxygen carriers.
    Frietsch T; Lenz C; Waschke KF
    Eur J Anaesthesiol; 1998 Sep; 15(5):571-84. PubMed ID: 9785073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The use of perftoran in clinical medicine].
    Moroz VV; Kruylov NL; Ivanitskii GR; Kaidash AN; Onishchenko NA; Simanov VA; Vorob'ev SI
    Anesteziol Reanimatol; 1995; (6):12-7. PubMed ID: 8713413
    [No Abstract]   [Full Text] [Related]  

  • 23. Perfluorocarbons as oxygen-transport fluids.
    Lowe KC
    Comp Biochem Physiol A Comp Physiol; 1987; 87(4):825-38. PubMed ID: 2887381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A second-generation blood substitute (perflubron emulsion) increases the blood solubility of modern volatile anesthetics in vitro.
    Cuignet OY; Baele PM; Van Obbergh LJ
    Anesth Analg; 2002 Aug; 95(2):368-72, table of contents. PubMed ID: 12145053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Non-ionogenic surface-active agents as a component of oxygen carrying fluorocarbon blood substitutes].
    Afonin NI; Rybolovleva IuR; Putiatina TK; Aprosin IuD; Doronina NN
    Probl Gematol Pereliv Krovi; 1982 Oct; 27(10):12-4. PubMed ID: 7178045
    [No Abstract]   [Full Text] [Related]  

  • 26. [What is the therapeutic effectiveness of organofluorine emulsions substituting in acute blood loss?].
    Iarkochkin VS; Volos OP; Koziner VB
    Gematol Transfuziol; 1991 Oct; 36(10):38-9. PubMed ID: 1778394
    [No Abstract]   [Full Text] [Related]  

  • 27. Modeling of oxygen uptake in perfluorocarbon emulsions. Some comparisons with uptake by blood.
    Shah N; Mehra A
    ASAIO J; 1996; 42(3):181-9. PubMed ID: 8725685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Doping with artificial oxygen carriers: an update.
    Schumacher YO; Ashenden M
    Sports Med; 2004; 34(3):141-50. PubMed ID: 14987124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Physicochemical and biological properties of hemoglobin modified with synthetic polymers].
    Kozlov AA; Livshits AB; Shtil'man MI; Berkovskiĭ AL; Krylov VE
    Gematol Transfuziol; 1984 Mar; 29(3):35-9. PubMed ID: 6546923
    [No Abstract]   [Full Text] [Related]  

  • 30. Present trends in fluorocarbon-based blood substitutes.
    Riess JG
    Life Support Syst; 1984; 2(4):273-6. PubMed ID: 6527557
    [No Abstract]   [Full Text] [Related]  

  • 31. Overview of progress in the fluorocarbon approach to in vivo oxygen delivery.
    Riess JG
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):183-202. PubMed ID: 1391434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical potential of intravenously administered perfluorocarbons.
    Habler O; Kleen M; Messmer K
    Acta Anaesthesiol Scand Suppl; 1997; 111():256-8. PubMed ID: 9421036
    [No Abstract]   [Full Text] [Related]  

  • 33. [Gas chromatographic method of determining polydispersion in the staged centrifugation of perfluoro compound emulsions as bases for a complex oxygen-carrier blood substitute].
    Sidliarov DP; Alekseeva VK; Afonin NI
    Probl Gematol Pereliv Krovi; 1982 Feb; 27(2):59-62. PubMed ID: 7063472
    [No Abstract]   [Full Text] [Related]  

  • 34. Perfluorocarbon-based oxygen delivery.
    Riess JG
    Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(6):567-80. PubMed ID: 17090429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The use of perfluorocarbon emulsions for suppression of rejection reaction in kidney allotransplantation].
    Ilgiavishute IaS; Zhukauskas GIu; Dapshis KL; Onishchenko NA
    Khirurgiia (Mosk); 1993 May; (5):16-8. PubMed ID: 8089979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perfluorochemical emulsions: potential clinical uses and new developments.
    Levine EM; Tremper KK
    Int Anesthesiol Clin; 1985; 23(1):211-30. PubMed ID: 3884515
    [No Abstract]   [Full Text] [Related]  

  • 37. On the perfluorocarbon emulsions of second generation.
    Meinert H; Fackler R; Knoblich A; Mader J; Reuter P; Röhlke W
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(1):95-113. PubMed ID: 1617088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Problem of creating "artificial blood" based on organofluorine compounds].
    Iarochkin VS; Koziner VB
    Patol Fiziol Eksp Ter; 1981; (3):78-87. PubMed ID: 6456440
    [No Abstract]   [Full Text] [Related]  

  • 39. [Successive replacement of fatal blood loss in dogs with polyglucin and perfluorocarbon emulsion].
    Akhsianov UU; Afonin NI
    Biull Eksp Biol Med; 1984 Aug; 98(8):160-2. PubMed ID: 6205706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluorocarbons. Current status and future applications.
    Faithfull NS
    Anaesthesia; 1987 Mar; 42(3):234-42. PubMed ID: 3555149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.